Specialty plays

Rather than sticking to its bread-and-butter disease areas of immunology, neurology and oncology, Biogen Idec Inc. has decided the best way to grow its pipeline is to look for external opportunities in niche markets. In Syntonix Pharmaceuticals Inc., the company thinks it may have found a hemophilia program that could shift the treatment paradigm in

Read the full 555 word article

How to gain access

Continue reading with a
two-week free trial.